Haleon plc

Equities

HLN

GB00BMX86B70

Pharmaceuticals

Market Closed - London S.E. 11:35:07 2024-05-16 EDT 5-day change 1st Jan Change
332.4 GBX +0.33% Intraday chart for Haleon plc +1.28% +3.34%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
GSK to Sell Remaining Stake in Haleon Valued at Around $1.27 Billion -- Update DJ
GSK intends to sell its remaining stake in Haleon RE
GSK to Sell Stake in Haleon Valued at About $1.61 Billion DJ
GSK to sell remaining holding in spin-off Haleon AN
GSK Plans to Sell 385 Million Haleon Shares MT
GSK intends to sell its entire stake in Haleon RE
GSK Intends To Sell About 385 Mln Shares In Haleon RE
GSK plc : Back on track Our Logo
Deutsche Bank likes TP ICAP but says sell CMC AN
HALEON : Q1 profitability beat; guidance unchanged Alphavalue
FTSE 100 down ahead of US interest rate decision AN
Haleon Q1 Revenue Declines 2.2% Year on Year MT
Haleon plc Announces Directorate Change CI
Haleon plc Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Transcript : Haleon plc, Q1 2024 Sales/ Trading Statement Call, May 01, 2024
Haleon backs guidance as profit edges up in first quarter AN
FTSE 100 shakes off New York slump before Fed AN
Sensodyne-maker Haleon posts tepid sales as demand for some products cools off RE
Haleon's first-quarter revenue misses expectations RE
GSK ups outlook; Next first-quarter beats forecast AN
Haleon Pretax Profit Rises Despite Revenue Drop DJ
Haleon Posts Higher Q1 Attributable Profit; Revenue Down MT
Tranche Update on Haleon plc's Equity Buyback Plan announced on September 11, 2023. CI
Sensodyne maker Haleon to shut UK factory with loss of 435 jobs AN
Haleon to Cut 435 Jobs, Shut U.K. Production Site DJ
Chart Haleon plc
More charts
Haleon plc specializes in the research, manufacture and marketing of drugs and consumer pharmaceutical products. Net sales break down by family of products as follows: - oral health products (27.7%; no. 1 worldwide): Sensodyne, Parodontax, Polident, Biotene, Aquafresh brands, etc.; - Pain relief medicines (23.5%; no. 1 worldwide): Panadol, Advil, Voltaren, Excedrin brands, etc.; - medicines for digestive health (18.9%; no. 1 worldwide): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium brands, etc.; - respiratory medicines (15.4%; no. 1 worldwide): Theraflu, Otrivin, Flonase, Contac brands, etc.; - vitamins, minerals and food supplements (14.5%; no. 1 worldwide): Centrum, Emergen-C, Caltrate brands, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa/Latin America (40.2%), North America (37.1%), and Asia/Pacific (22.7%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
3.324 GBP
Average target price
3.595 GBP
Spread / Average Target
+8.14%
Consensus
  1. Stock Market
  2. Equities
  3. HLN Stock
  4. News Haleon plc
  5. Jefferies Upgrades Haleon to Buy from Hold, Lifts PT
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW